NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

子宮頸癌診斷檢驗的全球市場:醫療設備的開發平台評估

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 366601
出版日期 內容資訊 英文 56 Pages
訂單完成後即時交付
價格
子宮頸癌診斷檢驗的全球市場:醫療設備的開發平台評估 Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年11月30日內容資訊: 英文 56 Pages
簡介

本報告提供全球子宮頸癌診斷檢驗相關產品市場上的主要開發中產品及其臨床實驗的進展調查,再彙整產品功能·特性比較分析 (臨床實驗的各進展階段) ,與主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 子宮頸癌診斷檢驗概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 子宮頸癌診斷檢驗的企業:各臨床實驗階段的開發中產品
  • 子宮頸癌診斷檢驗:各臨床實驗階段的開發中產品

第5章 子宮頸癌診斷檢驗市場:企業·產品概要

  • Abbott Diagnostics
    • 開發中產品及進行中的臨床實驗概要
  • Aindra Systems Pvt. Ltd.
  • Alere Inc.
  • Arbor Vita Corporation
  • Becton, Dickinson and Company
  • BioAffinity Technologies, Inc.
  • BioMark Diagnostics Inc.
  • BioMark Technologies Inc.
  • Cancer Research Technology Limited
  • Cepheid
  • China Sky One Medical, Inc.
  • Cytosystems Ltd
  • Enzo Life Sciences, Inc.
  • Genisphere Inc.
  • Genomic Vision
  • GenomicTree, Inc.
  • Golden Valley Development, Inc.
  • GRANT Life Sciences, Inc.
  • Louisville Bioscience, Inc.
  • MDNA Life Sciences, Inc.
  • MDxHealth SA
  • Milagen, Inc.
  • NeoDiagnostix, Inc.
  • Newcastle University
  • Oncgnostics GmbH
  • ONCOVEDA Cancer Research Center
  • Orion Genomics LLC
  • Precision Biologics, Inc.
  • Preciva Incorporated
  • Roche Diagnostics International Ltd.
  • University of Manchester
  • US Biomarkers, Inc.
  • Vanderbilt University
  • Vigilant Biosciences, Inc.
  • XEPTAGEN SpA

第6章 子宮頸癌診斷檢驗市場:目前的趨勢 (全24件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1028EPD

GlobalData's Medical Devices sector report, "Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cervical Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cervical Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient's sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cervical Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cervical Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cervical Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Cervical Cancer Overview

3 Products under Development

  • 3.1 Cervical Cancer - Pipeline Products by Stage of Development
  • 3.2 Cervical Cancer - Pipeline Products by Territory
  • 3.3 Cervical Cancer - Pipeline Products by Regulatory Path
  • 3.4 Cervical Cancer - Pipeline Products by Estimated Approval Date

4 Cervical Cancer - Pipeline Products under Development by Companies

  • 4.1 Cervical Cancer Companies - Pipeline Products by Stage of Development
  • 4.2 Cervical Cancer - Pipeline Products by Stage of Development

5 Cervical Cancer Companies and Product Overview

6 Cervical Cancer- Recent Developments

  • 6.1 Oct 26, 2020: Cervical cancer study compares Dalrada Health VIA screening kits to pap smear, peer reviewed journal - The Gynecologist - publishes findings
  • 6.2 Jul 31, 2020: New Cervical Cancer Screening Guidelines from the American Cancer Society risk reversing decades of progress made against Cervical Cancer
  • 6.3 Jun 24, 2020: Cancer Genetics reports first quarter 2020 financial results and provides strategic business updates
  • 6.4 Mar 12, 2020: Roche gets FDA approval for cytology test to prevent cervical cancer
  • 6.5 Feb 26, 2020: MDxHealth reports financial year 2019 results and provides outlook for 2020
  • 6.6 Feb 06, 2020: BD announces results for 2020 first fiscal quarter; lowers fiscal 2020 guidance
  • 6.7 Jan 30, 2020: Quest Diagnostics reports record fourth quarter and full year 2019 revenues and earnings; provides guidance for full year 2020; increases dividend 5.7% to $0.56 per quarter
  • 6.8 Jan 30, 2020: Genomic Vision: Financial information for the fourth quarter of 2019
  • 6.9 Nov 20, 2019: Cancer Genetics reports third quarter 2019 financial results and provides strategic business update
  • 6.10 Nov 12, 2019: Cancer Research UK appoints new Executive Director of Fundraising and Marketing

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us

List of Tables

List of Tables

  • Table 1: Cervical Cancer - Pipeline Products by Stage of Development
  • Table 2: Cervical Cancer - Pipeline Products by Territory
  • Table 3: Cervical Cancer - Pipeline Products by Regulatory Path
  • Table 4: Cervical Cancer - Pipeline Products by E

List of Figures

List of Figures

  • Figure 1: Cervical Cancer - Pipeline Products by Stage of Development
  • Figure 2: Cervical Cancer - Pipeline Products by Territory
  • Figure 3: Cervical Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Cervical Cancer - Pipeline Products